Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine in Metastatic Colorectal Cancer
NCT06134388Phase 3Recruiting
- Sponsor
- Tanta University
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminosalicylic acid + sulphasalazine in metastatic colorectal cancer (mCRC), sponsored by Tanta University. Started Sep 2023; status: recruiting.
02
Drugs
5-aminosalicylic acid + sulphasalazine
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT06134388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06134388.